Volitionrx Net Receivables from 2010 to 2025

VNRX Stock  USD 0.55  0.01  1.85%   
Volitionrx Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables is likely to outpace its year average in 2025. During the period from 2010 to 2025, Volitionrx Net Receivables regression line of annual values had r-squared of  0.53 and arithmetic mean of  61,125. View All Fundamentals
 
Net Receivables  
First Reported
2012-03-31
Previous Quarter
166.3 K
Current Value
312.6 K
Quarterly Volatility
88.6 K
 
Yuan Drop
 
Covid
Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 267.6 K, Other Operating Expenses of 44.4 M or Total Operating Expenses of 44.4 M, as well as many indicators such as Price To Sales Ratio of 71.97, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.
  
Check out the analysis of Volitionrx Correlation against competitors.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Latest Volitionrx's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Volitionrx over the last few years. It is Volitionrx's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Volitionrx Net Receivables Regression Statistics

Arithmetic Mean61,125
Geometric Mean16,864
Coefficient Of Variation173.52
Mean Deviation80,337
Median7,118
Standard Deviation106,063
Sample Variance11.2B
Range285.8K
R-Value0.73
Mean Square Error5.7B
R-Squared0.53
Significance0
Slope16,235
Total Sum of Squares168.7B

Volitionrx Net Receivables History

2025293 K
2024279 K
2023242.6 K
202272.6 K
202112.5 K

About Volitionrx Financial Statements

Volitionrx investors use historical fundamental indicators, such as Volitionrx's Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables279 K293 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.